Cystinuria is well-suited for gene therapy, mainly because of the disease’s autosomal recessive nature and manageable gene sizes (SLC3A1 2.3 kb, SLC7A9 1.8 kb), also, the core of the pathogenic mechanisms is located in the proximal tubule, which is easily accessible. The gene discussed is SLC3A1; the disease is cystinuria.